Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Doi

Showing results (631-640 of 635) with videos related to

Pageof 64
Sort By:
You have reached the last page of results.This site can display upto 635 results.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1997
[Clinical statistics on in-patients and operations during a 20-year period (1975-1994) at Department of Urology, Kansai Medical University]H Kawamura, S Kawakita, H Satoh, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled TrialT Sugimoto, T Sakurai, H Akatsu, et al.
Nature|March 20, 1997
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infectionH Suzuki, Y Kurihara, M Takeya, et al.
ESMO Open|November 19, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 studyJ-P Metges, K Kato, J-M Sun, et al.
ESMO Open|January 1, 2022
Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in AsiaY Cao, S Qin, S Luo, et al.
Pageof 64

Showing results (631-640 of 635) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 635 results.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1997
[Clinical statistics on in-patients and operations during a 20-year period (1975-1994) at Department of Urology, Kansai Medical University]H Kawamura, S Kawakita, H Satoh, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled TrialT Sugimoto, T Sakurai, H Akatsu, et al.
Nature|March 20, 1997
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infectionH Suzuki, Y Kurihara, M Takeya, et al.
ESMO Open|November 19, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 studyJ-P Metges, K Kato, J-M Sun, et al.
ESMO Open|January 1, 2022
Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in AsiaY Cao, S Qin, S Luo, et al.
Pageof 64